GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

BIOAB

290

-7.29%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Elenco Azioni・Camurus AB

Camurus AB

Chiusa

723.5 -0.07

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

716

Massimo

730

Metriche Chiave
By Trading Economics
Entrata	53M 292M
Vendite	117M 676M
P/E Media del settore	59.883 35.733
EPS	4.08
Margine di Profitto	43.235
Dipendenti	267
EBITDA	54M 315M

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	1.8B 43B
Apertura precedente	723.57
Chiusura precedente	723.5

Camurus AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 set 2025, 16:09 UTC

Acquisizioni, Fusioni, Takeovers

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

5 set 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

5 set 2025, 20:37 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

5 set 2025, 20:37 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

5 set 2025, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

5 set 2025, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

5 set 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

5 set 2025, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

5 set 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

5 set 2025, 20:20 UTC

Utili

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 set 2025, 19:23 UTC

Discorsi di Mercato

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

5 set 2025, 19:22 UTC

Utili

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

5 set 2025, 19:17 UTC

Discorsi di Mercato

U.S. Natural Gas Snaps Winning Streak -- Market Talk

5 set 2025, 18:59 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5 set 2025, 18:35 UTC

Discorsi di Mercato

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

5 set 2025, 17:25 UTC

Discorsi di Mercato

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

5 set 2025, 17:20 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

5 set 2025, 17:17 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

5 set 2025, 17:17 UTC

Discorsi di Mercato

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

5 set 2025, 17:03 UTC

Discorsi di Mercato

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5 set 2025, 16:39 UTC

Acquisizioni, Fusioni, Takeovers

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Global Equities Roundup: Market Talk

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Global Energy Roundup: Market Talk

5 set 2025, 16:37 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

5 set 2025, 16:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

5 set 2025, 16:16 UTC

Utili

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

5 set 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Camurus AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Camurus AB

Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain and Brixadi to treat opioid use disorder. Its products pipeline also includes CAM2038 for the treatment of chronic pain; CAM2029, which is in phase III clinical trials for the treatment of acromegaly and neuroendocrine tumors, as well as in phase II clinical trial to treat polycystic liver diseases; and CAM2043 that is in phase I clinical trial for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trial to treat Raynaud's phenomenon. In addition, the company is developing CAM2032, which is in phase II clinical trials for the treatment of prostate cancer; CAM4072 that is in phase III clinical trials for the treatment of genetic obesity disorders; CAM4071, which is in phase I clinical trials for the treatment of endocrine disorder; and CAM2047 that is in phase 1 clinical trial for the treatment of chemotherapy-induced nausea and vomiting. It has strategic partnerships with Braeburn Pharmaceuticals to develop CAM2038 for the treatment of opioid use disorder; and Rhythm Pharmaceuticals Inc. to develop CAM4072 for the treatment of a range of rare genetic disorders of obesity, as well as licensing agreement with Solasia Pharma. Camurus AB (publ) was founded in 1991 and is headquartered in Lund, Sweden.